Production (Stage)
Sagimet Biosciences Inc.
SGMT
$3.55
$0.051.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -57.11M | -45.57M | -37.52M | -29.25M | -27.92M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.55M | 4.18M | 4.01M | 4.84M | 4.92M |
| Change in Net Operating Assets | 1.80M | -1.05M | -4.99M | 1.60M | 106.00K |
| Cash from Operations | -50.76M | -42.44M | -38.49M | -22.80M | -22.89M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -61.27M | -61.68M | -91.15M | -91.78M | -3.82M |
| Cash from Investing | -61.27M | -61.68M | -91.15M | -91.78M | -3.82M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 105.86M | 109.38M | 195.55M | 195.55M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -27.00K | -1.05M | -4.56M | -3.52M | -4.40M |
| Cash from Financing | -27.00K | 104.82M | 104.82M | 192.03M | 191.15M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -112.06M | 701.00K | -24.83M | 77.45M | 164.44M |